Biogen Inc
DUS:IDP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biogen Inc
DUS:IDP
|
US |
|
Hoegh Autoliners ASA
OTC:HOEGF
|
NO |
|
R
|
Redhill Biopharma Ltd
F:2RH
|
IL |
|
K
|
Kingspan Group PLC
DUS:KRX
|
IE |
|
A
|
Allakos Inc
F:37Z
|
US |
Wall St Price Targets
IDP Price Targets Summary
Biogen Inc
According to Wall Street analysts, the average 1-year price target for IDP is 197.33 EUR with a low forecast of 133.52 EUR and a high forecast of 277.62 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IDP's stock price target?
Price Target
197.33
EUR
According to Wall Street analysts, the average 1-year price target for IDP is 197.33 EUR with a low forecast of 133.52 EUR and a high forecast of 277.62 EUR.
What is the Revenue forecast for Biogen Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Biogen Inc?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 6%.
What is the Net Income forecast for Biogen Inc?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 8 years is 13%.
